Charles Faith L., associated with Conduit Pharmaceuticals, has reported a future transaction scheduled for 12/18/2024. The nature and details of this transaction are not specified in the current disclosure.The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103. While the announcement indicates a planned action, it does not provide information on the type of securities involved, the quantity, or the transaction's value.Investors should note that this is a forward-looking report and the actual transaction may be subject to change. The lack of specific details in the current disclosure limits the ability to assess the potential impact on the company's stock or Faith's position within Conduit Pharmaceuticals.

Charles Faith L., associated with Conduit Pharmaceuticals, has reported a future transaction scheduled for 12/18/2024. The nature and details of this transaction are not specified in the current disclosure.The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103. While the announcement indicates a planned action, it does not provide information on the type of securities involved, the quantity, or the transaction's value.Investors should note that this is a forward-looking report and the actual transaction may be subject to change. The lack of specific details in the current disclosure limits the ability to assess the potential impact on the company's stock or Faith's position within Conduit Pharmaceuticals.